Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis Versus Stenting

PHASE1TerminatedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

July 31, 2012

Study Completion Date

October 31, 2012

Conditions
Coronary Artery DiseaseAtherosclerosis
Interventions
OTHER

Stenting and micro-infusion of NP

Step 1 - IVUS, OCT-guided put in everolimus-eluting (drug-eluting-DES) stent + intravascular ultrasound (IVUS) mapping + harvesting stem cells with mesenchymal phenotype; Step 2 - culturing of stem cells in medium by gold nanoparticles with silica-iron oxide shells; Step 3 - micro-infusion of stem cells bearing NP into the lesion; Step 4 - detonation of nanoshells after migration of stem cells with NPs inside (until 7-10 days after transplantation). We expect 'melting' and 'burning' effects of PPTT, beneficial effects of bioactive products of stem cells lysis + benefits from further migration of stem cells from patch into the plaque

DEVICE

Implantation of everolimus-eluting stent

Put stent in ischemia-related coronary artery by indications for PCI

Trial Locations (3)

620000

Ural Center of Modern Nanotechnologies, Institute of Natural Sciences, Ural Federal University, Yekaterinburg

620144

Ural Institute of Cardiology, Yekaterinburg

3071PR

De Haar Research Foundation, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Ural Institute of Cardiology

OTHER

collaborator

De Haar Research Foundation

OTHER

collaborator

Ural Federal University

OTHER

lead

Ural State Medical University

OTHER